Published on
International collaboration aims to ensure more equitable access to transformative personalized cancer therapy.
Published on
Whitehead received life-saving treatment at CHOP, under the care of Dr. Stephan Grupp, transforming the field of cancer immunotherapy.
Published on
Emily Whitehead, now 17, received life-saving treatment at CHOP, transforming the field of cancer immunotherapy.
Published on
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Published on
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.
Published on
A cell and gene therapy expert, Grupp discussed progress in clinical care in the 50 years since the legislation was signed.
Published on
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Published on
Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology, has been elected into the National Academy of Medicine (NAM).
Published on
The National Academy of Medicine elects two global leaders in cellular and gene therapy from Children’s Hospital of Philadelphia.
Published on
A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.